Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Petit

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Haematologica|February 16, 2005
Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroupBarbara Petit, Marie-Pierre Chaury, Christophe Le Clorennec, et al.
Histopathology|May 6, 2009
Among 157 marginal zone lymphomas, DBA.44(CD76) expression is restricted to tumour cells infiltrating the red pulp of the spleen with a diffuse architectural patternBarbara Petit, Marie Parrens, Isabelle Soubeyran, et al.
The Journal of Clinical Endocrinology and Metabolism|February 22, 2007
Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrationsShoji Ichikawa, Vincent Guigonis, Erik A Imel, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 6, 2019
Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effectsHafidha Bentayeb, Marine Aitamer, Barbara Petit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcomeFrederic Baleydier, Anne-Valerie Decouvelaere, Julie Bergeron, et al.
Frontiers in Oncology|May 7, 2021
c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA StudyNathalie Faumont, Oussama Taoui, Davi Collares, et al.
Blood|December 3, 2010
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 studyArnaud Jaccard, Nathalie Gachard, Benoit Marin, et al.
British Journal of Cancer|August 19, 2015
Anti-apoptotic role and clinical relevance of neurotrophins in diffuse large B-cell lymphomasLydie Dubanet, Hafidha Bentayeb, Barbara Petit, et al.
Blood|December 8, 2009
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal typeYenlin Huang, Aurélien de Reyniès, Laurence de Leval, et al.
The American Journal of Surgical Pathology|March 20, 2009
Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomasYenlin Huang, Anne Moreau, Jehan Dupuis, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Haematologica|February 16, 2005
Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroupBarbara Petit, Marie-Pierre Chaury, Christophe Le Clorennec, et al.
Histopathology|May 6, 2009
Among 157 marginal zone lymphomas, DBA.44(CD76) expression is restricted to tumour cells infiltrating the red pulp of the spleen with a diffuse architectural patternBarbara Petit, Marie Parrens, Isabelle Soubeyran, et al.
The Journal of Clinical Endocrinology and Metabolism|February 22, 2007
Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrationsShoji Ichikawa, Vincent Guigonis, Erik A Imel, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 6, 2019
Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effectsHafidha Bentayeb, Marine Aitamer, Barbara Petit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcomeFrederic Baleydier, Anne-Valerie Decouvelaere, Julie Bergeron, et al.
Frontiers in Oncology|May 7, 2021
c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA StudyNathalie Faumont, Oussama Taoui, Davi Collares, et al.
Blood|December 3, 2010
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 studyArnaud Jaccard, Nathalie Gachard, Benoit Marin, et al.
British Journal of Cancer|August 19, 2015
Anti-apoptotic role and clinical relevance of neurotrophins in diffuse large B-cell lymphomasLydie Dubanet, Hafidha Bentayeb, Barbara Petit, et al.
Blood|December 8, 2009
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal typeYenlin Huang, Aurélien de Reyniès, Laurence de Leval, et al.
The American Journal of Surgical Pathology|March 20, 2009
Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomasYenlin Huang, Anne Moreau, Jehan Dupuis, et al.
Pageof 3